Melatonin Inhibits AGS Cell Proliferation by Binding to the ATP Binding Site of CDK2 Under Hyperglycemic Conditions
Cell Biochemistry and Biophysics · 2024-06 · 82 (2) · 895-908
DOI: 10.1007/s12013-024-01241-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 07.03.2024. Verfasst von Abhishek Chatterjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Immunology division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata, 700032, West Bengal, Indi…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Cell Proliferation, Cyclin-Dependent Kinase 2, Hyperglycemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: CSIR - Indian Institute of Chemical Biology.
Abstract (Originalsprache)
Cancer cells utilize glucose as their primary energy source. The aggressive nature of cancer cells is therefore enhanced in hyperglycemic conditions. This study has been adopted to investigate the therapeutic potential of melatonin against such aggressive proliferation of AGS cells-a human gastric cancer cell line, under hyperglycemic conditions. AGS cells were incubated with high glucose-containing media, and the effects of melatonin have been evaluated, therein. Cell proliferation, ROS generation, flow-cytometric analysis for cell cycle and apoptosis, wound healing, immunoblotting, zymography, reverse zymography assays, in-silico analysis, and kinase activity assays were performed to evaluate the effects of melatonin. We observed that melatonin inhibited the hyperglycemia-induced cell proliferation in a dose-dependent manner. It further altered the expression and activity of MMP-9 and TIMP-1. Moreover, melatonin inhibited AGS cell proliferation by arresting AGS cells in the G0/G1 phase after binding in the ATP binding site of CDK-2, thereby inhibiting its kinase activity. In association, a significant decrease in the expression of cyclin D1, cyclin E, CDK-4, and CDK-2 were observed. In conclusion, these findings suggest that melatonin has anti-gastric cancer potential. Melatonin could therefore be included in future drug designs for gastric cancer-hyperglycemia co-morbidity treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases and Immunology division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata, 700032, West Bengal, India.
- Infectious Diseases and Immunology division, CSIR-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata, 700032, West Bengal, India. snehasiktaiicbidi@gmail.com.
Förderung
- CSIR - Indian Institute of Chemical Biology
Zitieren
APA
Chatterjee, A., Roy, T., Jyothi, D., Mishra, V. K., Singh, U. P., & Swarnakar, S. (2024). Melatonin Inhibits AGS Cell Proliferation by Binding to the ATP Binding Site of CDK2 Under Hyperglycemic Conditions. Cell Biochemistry and Biophysics, 82(2), 895-908. https://doi.org/10.1007/s12013-024-01241-9
Vancouver
Chatterjee A, Roy T, Jyothi D, Mishra VK, Singh UP, Swarnakar S. Melatonin Inhibits AGS Cell Proliferation by Binding to the ATP Binding Site of CDK2 Under Hyperglycemic Conditions. Cell Biochemistry and Biophysics. 2024;82(2):895-908. doi:10.1007/s12013-024-01241-9
BibTeX
@article{Chatterjee2024,
author = {Chatterjee, Abhishek and Roy, Tapasi and Jyothi, Deeti and Mishra, Vineet Kumar and Singh, Umesh Prasad and Swarnakar, Snehasikta},
title = {Melatonin Inhibits AGS Cell Proliferation by Binding to the ATP Binding Site of CDK2 Under Hyperglycemic Conditions},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
volume = {82},
number = {2},
pages = {895--908},
doi = {10.1007/s12013-024-01241-9}
}
EUVIMED